UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 17, 2010
WORLD HEART CORPORATION
(Exact name of registrant as specified in charter)
Delaware | | 000-28882 | | 52-2247240 |
(State or other jurisdiction of
incorporation) | | (Commission
File Number) | | (IRS Employer
Identification No.) |
4750 Wiley Post Way, Suite 120, Salt Lake | | |
City, UT | | 84116 |
(Address of principal executive offices) | | (Zip Code) |
(801) 355-6255
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events.
On March 23, 2010, World Heart Corporation announced that the University of Utah Hospital in Salt Lake City, Utah has successfully implanted its first Levacor™ Ventricular Assist Device (VAD).
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit | | |
99.1 | | Press Release dated March 23, 2010 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: March 23, 2010 | |
| |
| | WORLD HEART CORPORATION |
| | |
| By: | /s/ Morgan Brown |
| Name: | Morgan Brown |
| Title: | Executive Vice President and Chief Financial Officer |
3
